IGFBP5 and type 2 diabetes mellitus: Finally, significantly suppressed expression of both IL-33 and IGFBP5 was noted in differentiated T2D IPFP-ASCs compared to undifferentiated T2D-IPFP ASCs (Figure 3F,I).